OTC Acne Treatment Devices Heat Up Competition With ERSP-Cleared Claims
This article was originally published in The Tan Sheet
The rise of beauty devices in recent years has generated buzz, but also skepticism about claims. In a review of La Lumiere’s illuMask home-use acne-treatment device, the Electronic Retailing Self-Regulatory Program finds the performance claims adequately substantiated, consistent with previous decisions.
You may also be interested in...
Presenting at the Independent Beauty Association’s Cosmetic Technical/Regulatory Forum, Product Integrity Laboratory’s Howard Baker dug into the less-discussed aspects of green packaging that “could damage your brand’s reputation, cause regulatory and legal problems, and severely harm the economics of your business.”
NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.
The beauty titan will increase its stake in DECIEM to 76% in a deal valuating The Ordinary skin-care owner at $2.2bn. Remaining interests will be acquired after three years, according to the announcement.